Translating innovation into access for ATMPs: third EU-Innovation network multi-stakeholder meeting

Date

, -

Location

Online
Rome, Italy
Live broadcast

Event summary

The EU-Innovation Network (EU-IN) and the Italian Medicines Agency (AIFA) are organising a multi-stakeholder meeting to discuss how innovation in the development of Advanced Therapy Medicinal Products (ATMPs) can be translated into effective and safe therapies at the point of care in Europe.

The objectives are:

  • seek feedback from developers on the main challenges and barriers currently encountered from early development to access,
  • provide insights on scientific and regulatory advice tools at European and national level available for developers,
  • discuss opportunities for promoting mutual exchange and interactions between stakeholders with the aim of strengthening the European Innovation Ecosystem.

The meeting provides an open forum for all stakeholders and aims to foster collaboration across the European Innovation Ecosystem.

Documents

Video recording

Survey

We plan to present ATMP developers' views on challenges and opportunities in the ATMP field at this meeting. Please consider contributing via this survey.

With this survey we would like:

  • to get feedback from developers on the perceived challenges and potential opportunities for improvement for ATMPs development and early access;
  • to investigate developers' awareness and experience of the current available EU regulatory support tools;
  • to understand developers' expectations with regard to regulators' role in EU public and public-private funded projects.

Access the survey:

Translating innovation into access for ATMPs

Share this page